A Phase II Study of CLAG Regimen Combined With Imatinib Mesylate for Relapsed or Refractory Acute Myeloid Leukemia
2017 ◽
Vol 17
(12)
◽
pp. 902-907
◽
2011 ◽
Vol 11
(5)
◽
pp. 433-438
◽
2012 ◽
Vol 12
(5)
◽
pp. 341-344
◽
2003 ◽
Vol 71
(3)
◽
pp. 155-162
◽